AMN Healthcare Services, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual filing, not a standalone Q4 report; the filing text does not provide a complete set of fourth-quarter financial results.
Business context
AMN provides healthcare staffing, managed services, recruitment, language interpretation, workforce technology and related solutions, primarily in the United States. Its three reportable segments are nurse and allied solutions; physician and leadership solutions; and technology and workforce solutions. MSP relationships generated approximately 54% of consolidated revenue in 2023, versus 64% in 2022. Kaiser Foundation Hospitals and affiliates represented approximately 17% of 2023 revenue.
Financial performance
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Revenue | $3,789.3 million | $5,243.2 million | Down 28% |
| Gross profit / margin | $1,249.6 million / 33.0% | $1,716.7 million / 32.7% | Profit down 27%; margin up 0.3 percentage points |
| Operating income / margin | $338.4 million / 8.9% | $647.1 million / 12.3% | Down 48% |
| Net income / margin | $210.7 million / 5.6% | $444.1 million / 8.5% | Down 53% |
| Diluted earnings per share | $5.36 | $9.90 | Down 46% |
| Operating cash flow | $372.2 million | $653.7 million | Down $281.6 million |
| Capital expenditures | $103.7 million | $75.8 million | Up $27.9 million |
Segment revenue: Nurse and allied solutions generated $2,624.5 million, down 34%; physician and leadership solutions generated $669.7 million, down 4%; technology and workforce solutions generated $495.0 million, down 12%.
Liquidity and debt: Year-end cash and cash equivalents were $32.9 million; current assets were $841.7 million and current liabilities were $656.1 million. Total debt, net of fees and premium, was $1,304.7 million, including $460 million drawn on the revolving facility and $850 million of senior notes. The $750 million facility had $269.2 million of available credit at year-end, after letters of credit. Management stated operating cash flow and available facility borrowings should cover operations and liquidity needs, including expected capital expenditures, for the next 12 months and beyond.
Material changes and drivers
- Revenue fell primarily as pandemic-era staffing demand and bill rates normalized and healthcare organizations hired permanent staff, reducing contingent labor use. Nurse and allied revenue declined with fewer travelers, lower average bill rates and reduced labor-disruption revenue.
- Travel nurse demand declined significantly early in 2023, then stabilized in the third and fourth quarters but remained below pre-pandemic levels. Staffing volume was relatively flat sequentially in Q4; bill rates continued to decline, but at a slower pace.
- Locum tenens revenue grew 9%, supported by higher revenue per day filled and the MSDR acquisition. Language services revenue grew 20%, as minutes increased 24%. These gains partially offset declines in interim leadership, VMS and other staffing lines.
- Gross margin increased slightly, reflecting segment and service mix, while operating and net margins contracted amid lower revenue, higher depreciation and amortization, and increased interest expense. Interest expense, net and other rose to $54.1 million from $40.4 million.
- Operating cash flow declined amid lower earnings and working-capital movements. Investing cash use rose to $412.5 million, including $292.2 million for acquisitions and $103.7 million of capital expenditures.
Outlook, risks and unusual items
- No formal financial guidance is provided in the supplied filing text. Management expected locum tenens demand to remain above pre-pandemic levels and bill rates across nurse and allied staffing to remain above pre-pandemic levels; it also described Q4 travel nurse demand as stable but subdued.
- AMN acquired MSDR, a locum tenens and advanced-practice staffing business, on November 30, 2023 for an initial $292.8 million in cash, funded by revolving-credit borrowings. The purchase-price allocation included $175.8 million of goodwill and $92.0 million of identified intangible assets; allocation remained preliminary.
- The company recorded a $62 million accrual for the Clarke wage-and-hour matter settlement, which had preliminary approval in Q4 2023; final approval was expected in Q2 2024. Management said it could not estimate potential losses beyond amounts accrued. The filing identifies wage-and-hour actions, employment practices, professional liability, tax and other legal matters as ongoing contingencies.
- Key risks include continued normalization or further weakness in contingent staffing demand and rates, client cost pressure, clinician recruitment and retention, customer concentration, cybersecurity and technology disruption, regulatory and worker-classification changes, and acquisition integration. Variable-rate revolving debt exposes AMN to interest-rate risk. The company reported immaterial cyber incidents and expects cyber threats to continue.
- AMN plans to wind down Synzi and SnapMD operations during 2024; it recorded an immaterial intangible-asset impairment and said the wind-down was not expected to materially affect consolidated financial statements.
- AMN repurchased $424.7 million of shares during 2023, including a $200 million accelerated repurchase, and had $226.7 million of authorization remaining at year-end. These repurchases contributed to higher debt and lower stockholders’ equity.
Most important facts for investors to verify
- Whether travel nurse demand and bill rates have stabilized or improved since year-end, and how staffing volume is trending.
- Whether cash generation, working capital and days sales outstanding (70 days at year-end, or 66 excluding MSDR) improve as revenue levels change.
- Debt balances, revolver availability, interest costs and compliance with credit-agreement covenants; AMN reported covenant compliance at December 31, 2023.
- Final MSDR purchase accounting and integration performance, alongside the planned Synzi/SnapMD wind-down.
- Final approval and ultimate cost of the $62 million Clarke settlement, plus developments in other legal and insurance reserves.
- Customer concentration: Kaiser represented about 17% of consolidated revenue, making retention and contract economics material to results.